RiverVest Funds I, II & III RiverVest Fund IV Archer Seed Fund

28 Apr

Posted at 00:00h in RiverVest News by

AUG 2021Portfolio Company Amplyx Pharmaceuticals Acquired by Pfizer /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 26, 2021)Read the Press ReleaseNEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to...

24 Mar

Posted at 00:00h in RiverVest News by

MAR 2021What's next for RiverVest Venture Partners after raising its largest-ever investment fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 24, 2021)Read the Press ReleaseST. LOUIS, MO (Mar. 24, 2021) – From the St. Louis Business JournalRiverVest Venture Partners has...

23 Mar

Posted at 00:00h in RiverVest News by

MAR 2021RiverVest Venture Partners Closes $275 Million Life Sciences Fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 23, 2021)Oversubscribed fund to continue investing in high-impact biopharma and medical device innovationST. LOUIS (March 23, 2021) – RiverVest Venture Partners, a leading...

16 Feb

Posted at 00:00h in RiverVest News by

FEB 2021Pascal Krotee Joins RiverVest as Senior Associate /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (February 16, 2021)St. Louis, MO (Feb 16, 2021) – Life science venture capital firm RiverVest continues to expand its team with the addition of Pascal Krotee...